Collaboration Between Carson Leslie Foundation and CBTN
The Children's Brain Tumor Network (CBTN) is welcoming a new member to its Executive Council. The Carson Leslie Foundation is stepping up to join forces with CBTN, a partnership that promises to enhance the fight against pediatric brain tumors.
Impact of Recent Contributions
Over the past four years, the Carson Leslie Foundation has actively supported multiple projects under the CBTN umbrella. A notable recent contribution includes a significant donation of $100,000 aimed at advancing a medulloblastoma liquid biopsy project. This innovative project is expected to provide a less invasive method for tracking treatment progress in children suffering from this aggressive form of brain cancer.
Importance of Collaborative Efforts
As CBTN's Executive Director, Jena Lilly expresses, the inclusion of the Carson Leslie Foundation brings vital research expertise and advocacy to their initiatives. By combining resources and knowledge, they aim to improve the long-term outcomes for children diagnosed with brain tumors. With a shared mission to enhance the quality of life for young patients, this collaboration sets the stage for groundbreaking advancements in treatment methods.
About the Carson Leslie Foundation
The Carson Leslie Foundation was established in honor of Carson Leslie, a brave young individual who fought against medulloblastoma until 2010. This foundation is devoted to funding critical research aimed at developing effective treatments and, eventually, finding a cure for pediatric brain tumors.
Vision for the Future
Ripley Martin, a board member of the Carson Leslie Foundation, emphasizes the necessity for various pediatric brain tumor organizations to unite their efforts. He underlines the belief that through collaboration, real progress can be achieved, making a transformative difference in the lives of affected children.
About Children's Brain Tumor Network (CBTN)
CBTN serves as a collaborative research entity striving to ensure that no child suffers or succumbs to a brain tumor. Comprising 35 international member institutions, CBTN has enrolled over 7,000 participants and collected more than 70,000 biospecimen samples. This effort has resulted in the most extensive repository dedicated to childhood brain tumors globally. Their suite of innovative cloud-based informatics and analytics platforms empowers researchers to cooperate effectively in real-time, focusing on transformative outcomes for young patients.
Frequently Asked Questions
What is the Carson Leslie Foundation?
The Carson Leslie Foundation is dedicated to funding research aimed at improving treatments for pediatric brain tumors, named after a young boy who battled medulloblastoma.
What role does the Carson Leslie Foundation play in CBTN?
It acts as a valuable partner on the CBTN Executive Council, providing support, expertise, and funding to advance research and treatment for brain tumors in children.
What are the goals of CBTN?
CBTN aims to ensure that no child suffers from or dies due to brain tumors by facilitating research collaboration and collecting crucial data through their extensive biospecimen repository.
How does the medulloblastoma project impact treatment?
The medulloblastoma liquid biopsy project is designed to offer less invasive tracking of treatment progress, potentially leading to better outcomes for children undergoing therapy for this cancer.
Why is collaboration in pediatric brain tumor research important?
Collaboration allows organizations to share resources, knowledge, and innovative ideas, which can lead to significant advancements in treatment and care for affected children.
